Sinopharm
1099.HK
#2044
Rank
ยฃ5.67 B
Marketcap
ยฃ1.82
Share price
0.76%
Change (1 day)
-12.47%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): ยฃ52.27 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ64.41 Billion. an increase over the revenue in the year 2022 that were of ยฃ61.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 ยฃ64.41 B5.42%
2022 ยฃ61.10 B-2.1%
2021ยฃ62.41 B16.85%
2020ยฃ53.41 B14.95%
2019ยฃ46.46 B21.52%
2018ยฃ38.23 B5.93%
2017ยฃ36.09 B27.22%
2016ยฃ28.37 B5.37%
2015ยฃ26.92 B9.14%
2014ยฃ24.66 B17.22%
2013ยฃ21.04 B25.94%
2012ยฃ16.71 B34.61%
2011ยฃ12.41 B55.34%
2010ยฃ7.99 B35.79%
2009ยฃ5.88 B37.56%
2008ยฃ4.27 B31.43%
2007ยฃ3.25 B40.26%
2006ยฃ2.32 B